Table 3 Demographic and baseline characteristics of the two patient groups after PSM (N = 322).

From: D-dimer, a predictor of bad outcome in gastric cancer patients undergoing radical resection

Characteristics

Total

NDG

EDG

P value

(N = 322)

(N = 161)

(N = 161)

Gender, no. (%)

0.211

Female

88(27.3)

39(24.2)

49(30.4)

 

Male

234(72.7)

122(75.8)

112(69.6)

 

Tumor location, no. (%)

0.011

proximal stomach

131(40.7)

78(48.4)

53(32.9)

 

distal stomach

145(45)

60(37.3)

85(52.8)

 

most or total stomach

46(14.3)

23(14.3)

23(14.3)

 

Age ≥ 65 years. No. (%)

157(48.8)

78(48.4)

79(49.1)

0.911

PT, second

13(12.4–13.53)

12.9(12.35–13.4)

13.1(12.6–13.7)

0.02

PTA, %

94.1(82.9–105.45)

94.45(86.2–108.5)

94.9(78.9–104.7)

0.142

PTR

1.03(0.99–1.08)

1.03(0.99–1.07)

1.02(0.99–1.08)

0.942

APTT, second

34.6(31.7–37)

1.02(0.98–1.07)

1.03(1–1.09)

0.669

INR

1.03(0.99–1.08)

34.5(32–37.2)

34.7(31.55–36.95)

0.086

TT, second

16.2(15.7–16.8)

16.2(15.75–16.75)

16.2(15.6–16.85)

0.953

FIB, g/l

3.35(2.71–4)

3.18(2.7–3.8)

3.44(2.81–4.2)

0.04

D-dimer, mg/l

1.01(0.3–1.71)

0.3(0.1–0.6)

1.7(1.2–2.75)

 < 0.001

FDP, mg/l

1.62(0.9–3.2)

1(0.6–1.3)

3.2(2.3–5.4)

 < 0.001

Platelet

199(153–252)

198(151–255.5)

200(155.8–250.5)

0.8

T stage, no. (%)

0.737

T1

33(10.2)

15(9.3)

18(11.2)

 

T2

20(6.2)

12(7.5)

8(5)

 

T3

81(25.2)

42(26.1)

39(24.2)

 

T4

188(58.4)

92(57.1)

96(59.6)

 

N stage, no. (%)

0.01

N0

91(28.3)

40(24.8)

51(31.7)

 

N1

50(15.5)

29(18)

21(13)

 

N2

77(23.9)

49(30.4)

28(17.4)

 

N3

104(32.3)

43(26.7)

61(37.9)

 

TNM stage, no. (%)

0.057

I

41(12.7)

17(10.6)

24(14.9)

 

II

53(16.5)

34(21.1)

19(11.8)

 

III

228(70.8)

110(68.3)

118(73.3)

 

Chemotherapy

0.204

yes

238(73.9)

114(70.8)

124(77)

 

no

84(26.1)

47(29.2)

37(23)

 

Histology, no. (%)

0.051

differentiated

123(38.2)

70(43.5)

53(32.9)

 

undifferentiated

199(61.8)

91(56.5)

108(67.1)

 

OS, month

24(13–44)

25(15–47.5)

19(10–42.4)

0.005

DFS, month

23(12–44)

24(14–48)

18.5(9–43.25)

0.007

LNR

0.21(0–0.44)

0.21(0–0.36)

0.21(0–0.57)

0.921

Tumor size, cm

4(3–5.5)

3(2.5–4)

4.5(3–6)

 < 0.001